Knight Initiative News

This week, we're taking a deep dive with psychiatrist Carolyn Rodriguez into the neuroscience of obsessive-compulsive disorder (OCD) and why a single dose of ketamine can erase the disorder for weeks at a time.

The Wu Tsai Neurosciences Institute’s sixth round of Neuroscience:Translate awards aim to accelerate promising discoveries from the lab to patient impact.

For those with stroke, involuntary contractions of the hands and arms often follow. A simple, wearable vibrating glove developed by Wu Tsai Neuro affiliates Allison Okamura, Caitlin Seim and others, may offer a more effective treatment.

The International Society for Stem Cell Research awards Sergiu P. Paşca the 2024 ISSCR Momentum Award for his achievements in neurodevelopment and disease.

Even just one night of less than six hours of rest can impair short-term memory according to experts, including Wu Tsai Neuro affiliate Sharon Sha.

A new study in rats by Institute affiliate Raag Airan — supported by a Wu Tsai Neuro seed grant — looked at whether ketamine’s effects depend on opioid pathways and uncovered a surprising difference between males and females.

Learn about the experience of several participants in the BrainGate brain-computer interface clinical trial, and the large team effort by Wu Tsai Neuro affiliates Jaimie Henderson, Paul Nuyujukian, and the late Krishna Shenoy over the past decade to get n

This week, we talk with psychiatrist Neir Eshel about dopamine, the difference between 'liking' and 'wanting,' and new ways of thinking about Parkinson's disease and addiction.

This week we talk with Jaimie Henderson, a Stanford neurosurgeon leading groundbreaking research in brain-machine interfaces.

NBC Bay Area’s Raj Mathai spoke to Wu Tsai Neuro Institute Scholar Paul Nuyujukian for insight on the first brain chip in a human patient.

Institute Scholar Paul Nuyujukian contributes to the discussion of Neuralink implanting a brain chip into a human.

In a live interview, Wu Tsai Neuro Institute Scholar Paul Nuyujukian tells NBC News how Neuralink technology works and the future of brain-computer interfaces.

Leaders of the Wu Tsai Neurosciences Institute reflect on a decade of boundary-breaking study of the brain and what lies ahead for Stanford’s widespread neurosciences community.

A 3D variation of pooled CRISPR screens could connect the dots between autism spectrum disorder genetics and cell fate pathways in the developing brain.

Neuroscientists have long been frustrated that they cannot access or examine brain tissue. But by reserve-engineering cells in the lab, Sergiu Pașca can now study brain disorders on a molecular level.

How to know if your organs are ‘older’ than you are, and ways to slow down biological aging according to Knight Initiative director Tony Wyss-Coray and others.

In a study supported by Wu Tsai Neuro's Neurochoice Initiative, researchers have delved into the complex relationship between brain activity and the risk of relapse in individuals recovering from stimulant addiction.

Knight Initiative director Tony Wyss-Coray and others are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age.

We are proud to welcome the 2024 Neurosciences Postdoctoral Scholars — ten young scientists pursuing novel, multi-disciplinary approaches to understanding the workings of the brain.

Inspired by Japanese paper art, a new device can record from 3D ‘organoid’ models of the developing human brain for months without disturbing their growth or structure.